Chlamydia vaccine - Antigenics
Latest Information Update: 24 Oct 2021
At a glance
- Originator Antigenics
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Chlamydial infections
Most Recent Events
- 20 Mar 2009 Discontinued - Preclinical for Chlamydial infections in USA (unspecified route)
- 14 Sep 2006 Preclinical trials in Chlamydial infections in USA (unspecified route)
- 27 Aug 2001 Aquila Biopharmaceuticals has been integrated into Antigenics